SIRT1 and chronic myelogenous leukemia, BCR-ABL1 positive: Sirt1 activation promotes chronic granulocytic leukemia (CML) cell survival, and proliferation is associated with the deacetylation of multiple SIRT1 substrates, including FoxO1, p53, and KU70.